Skip to main content
Image of syringe and pipets)

Therapeutic Areas and Products


Our world-leading immunoglobulin (Ig) franchise includes an intravenous and a subcutaneous option and is the cornerstone of the neurology therapeutic area. Our efforts in this area focus on bringing trusted products and technologies to serve patients with a rare and serious neurologic disease, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Conferences and Events

Muscle Study Group 2021 Annual Meeting
Oct 1st – 3rd 2021
Washington, DC | Meet Us

AANEM 2021 Annual Meeting
Oct 13th – 16th 2021
Aurora, CO | Meet Us

ANA 2021 Annual Meeting
Oct 17th – 19th 2021
Virtual | Meet Us

IgNS 2021 Annual Meeting
Oct 21st – 24th 2021
Las Vegas, NV | Meet Us

For U.S. Healthcare Professionals only

The purpose of this CSL Behring Medical Affairs website is to support Healthcare Professionals with scientific information. This website is also a channel for U.S. Healthcare Professionals to submit questions or connect with CSL Behring U.S. Healthcare Professionals. The information provided is for educational purposes only and is not intended to promote any products. By continuing to use this site you are acknowledging that you are a US Healthcare Professional